180 related articles for article (PubMed ID: 25243787)
1. Genetic variants in fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival.
Yin J; Liu H; Liu Z; Wang LE; Chen WV; Zhu D; Amos CI; Fang S; Lee JE; Wei Q
J Invest Dermatol; 2015 Feb; 135(2):542-550. PubMed ID: 25243787
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of nucleotide excision repair genes predict melanoma survival.
Li C; Yin M; Wang LE; Amos CI; Zhu D; Lee JE; Gershenwald JE; Grimm EA; Wei Q
J Invest Dermatol; 2013 Jul; 133(7):1813-21. PubMed ID: 23407396
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survival.
Yuan H; Liu H; Liu Z; Zhu D; Amos CI; Fang S; Lee JE; Wei Q
Int J Cancer; 2015 Aug; 137(3):638-45. PubMed ID: 25628125
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival.
Li H; Wang Y; Liu H; Shi Q; Xu Y; Wu W; Zhu D; Amos CI; Fang S; Lee JE; Han J; Wei Q
Int J Cancer; 2017 Mar; 140(6):1270-1279. PubMed ID: 27914105
[TBL] [Abstract][Full Text] [Related]
5. Genetic Variants in WNT2B and BTRC Predict Melanoma Survival.
Shi Q; Liu H; Han P; Li C; Wang Y; Wu W; Zhu D; Amos CI; Fang S; Lee JE; Han J; Wei Q
J Invest Dermatol; 2017 Aug; 137(8):1749-1756. PubMed ID: 28499756
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival.
Dai W; Liu H; Xu X; Ge J; Luo S; Zhu D; Amos CI; Fang S; Lee JE; Li X; Nan H; Li C; Wei Q
Int J Cancer; 2019 Nov; 145(10):2619-2628. PubMed ID: 30734280
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.
Li B; Wang Y; Xu Y; Liu H; Bloomer W; Zhu D; Amos CI; Fang S; Lee JE; Li X; Han J; Wei Q
Int J Cancer; 2018 Jun; 142(11):2303-2312. PubMed ID: 29313974
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival.
Dai W; Liu H; Chen K; Xu X; Qian D; Luo S; Amos CI; Lee JE; Li X; Nan H; Li C; Wei Q
Mol Carcinog; 2020 Jun; 59(6):640-650. PubMed ID: 32232919
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in TKT and DERA in the nicotinamide adenine dinucleotide phosphate pathway predict melanoma survival.
Gu N; Dai W; Liu H; Ge J; Luo S; Cho E; Amos CI; Lee JE; Li X; Nan H; Yuan H; Wei Q
Eur J Cancer; 2020 Sep; 136():84-94. PubMed ID: 32659474
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study.
Levran O; Diotti R; Pujara K; Batish SD; Hanenberg H; Auerbach AD
Hum Mutat; 2005 Feb; 25(2):142-9. PubMed ID: 15643609
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival.
Chen K; Liu H; Liu Z; Bloomer W; Amos CI; Lee JE; Li X; Nan H; Wei Q
Mol Carcinog; 2019 Nov; 58(11):2091-2103. PubMed ID: 31435991
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of SDCCAG8 and MAGI2 in mitosis-related pathway genes are independent predictors of cutaneous melanoma-specific survival.
He Y; Liu H; Luo S; Amos CI; Lee JE; Li X; Nan H; Wei Q
Cancer Sci; 2021 Oct; 112(10):4355-4364. PubMed ID: 34375487
[TBL] [Abstract][Full Text] [Related]
13. XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro), and GSTP1 (Ile105Val) polymorphisms in prognosis of cutaneous melanoma.
Gomez GV; de Oliveira C; Rinck-Junior JA; de Moraes AM; Lourenço GJ; Lima CS
Tumour Biol; 2016 Mar; 37(3):3163-71. PubMed ID: 26427666
[TBL] [Abstract][Full Text] [Related]
14. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
15. Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma.
Zhang W; Liu H; Liu Z; Zhu D; Amos CI; Fang S; Lee JE; Wei Q
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1101-10. PubMed ID: 25953768
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
17. Screening of the FANCA gene mutational hotspots in the Pakistani fanconi anemia patients revealed 19 sequence variations.
Shahid M; Firasat S; Satti HS; Satti TM; Ghafoor T; Sharif I; Afshan K
Congenit Anom (Kyoto); 2020 Jan; 60(1):32-39. PubMed ID: 30809872
[TBL] [Abstract][Full Text] [Related]
18. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic
Lach FP; Singh S; Rickman KA; Ruiz PD; Noonan RJ; Hymes KB; DeLacure MD; Kennedy JA; Chandrasekharappa SC; Smogorzewska A
Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33172906
[TBL] [Abstract][Full Text] [Related]
19. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
[TBL] [Abstract][Full Text] [Related]
20. [FANCA gene mutation analysis in Fanconi anemia patients].
Chen F; Peng GJ; Zhang K; Hu Q; Zhang LQ; Liu AG
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):616-8. PubMed ID: 16532972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
